13 Digital Health Companies Seek Distributors and Hospital Partners for Smart Surgery, Digital Diagnostics, and Health Management Solutions – National Day Special Matchmaking Edition
TRANSCEND VIVOSCOPE
TRANSCEND VIVOSCOPE
Beijing Yizhiying Technology Co., Ltd.
Medical Imaging Analysis Technology Service Provider
Ariemedi
Developer, Manufacturer, and Distributor of Intelligent Medical Devices
H&B
Stem Cell Collection, Storage, and Cell Therapy Service Provider
Boea Wisdom
AI Simulation Technology Developer
iRegene Therapeutics
Cell Therapy Product Developer
EBrain Scientific
Medical Electronic Instrument R&D and Manufacturer
- VCBeat "Supply and Demand Connection" industrial platform efficiently connects industry resources and boosts performance growth.
- As of now, VCBeat has launched nearly a thousand links, each with an exposure volume.1W+, achieving more than successful enterprise connections2,000 times
- Continuous curation and release of selected link collections, with precise delivery to VCBeat-related field communities (total coverage exceeding...3W+）
In recent years, with the gradual maturity and widespread application of new-generation information technologies such as cloud computing, the Internet of Things, mobile internet, big data, artificial intelligence, 5G networks, and blockchain, informatization has become a key driving force in promoting the construction of a modern health service system and the transformation and innovation of medical service models. Amidst the wave of digitalization and intelligentization, various new models, new business forms, new technologies, and new services continue to emerge, bringing unprecedented changes to the healthcare sector. VCBeatSupply and Demand Matching Links Selection - National Day Special, this issue has selected for everyone13 Innovative Medical Solutions, seeking high-quality channel partners, hospitals and other market collaborators, details as follows:
TRANSCEND VIVOSCOPE - China's First In Vivo Two-Photon Microscopy Imaging System
● Company/Product Introduction:
TRANSCEND VIVOSCOPE is a national high-tech enterprise specializing in the research, development, production, and sales of advanced biomedical imaging equipment. TRANSCEND VIVOSCOPE has successfully completed the productization of microscopes, solving the domestic bottlenecks of core technology components such as probes, special optical fibers, femtosecond lasers, and miniaturized objective lenses. It has achieved independent production of a series of miniaturized two-photon microscopic imaging systems, which are widely used in brain science research both in China and internationally.
The in vivo two-photon microscopy imaging system is an innovative medical imaging instrument that performs high-resolution three-dimensional sectional scanning and imaging of epithelial cells and tissues on the surface of the skin.
The instrument itself consists of two parts: the main unit and the handle. The main unit and handle are connected by a flexible photoelectric composite cable. The ergonomic handle design allows operators to quickly examine various parts of the subject's body, with the entire device weighing only 13kg. This instrument can assist in identifying tissue composition and help assess metabolic function, providing a new paradigm of multimodal imaging for clinical dermatology and scientific research. It offers a convenient option for researchers, doctors, and professionals in skin-related industries, including cosmetics and beauty.
●Demand Description:
Seeking distributors and partners across China. Interested parties are welcome to communicate.
Beijing Yizhiying Technology Co., Ltd. -One-Stop Solution for Tumor Radiotherapy
●Company/Product Introduction:
Founded in July 2019, Beijing Yizhiying Technology Co., Ltd. is a medical AI enterprise that develops "precise tumor treatment solutions" based on medical big data and artificial intelligence technology. The company focuses on clinical target area delineation for tumor treatment and has completed clinical target volume (CTV) delineation solutions for breast cancer, rectal cancer, cervical cancer, lung cancer, esophageal cancer, total marrow irradiation (TMI), pediatric tumors, and more. It also provides fully automated delineation for over 120 organs at risk across the entire body. The company has independently developed core products such as the "Radiation Therapy Contouring Software RT-Mind," "Intelligent Radiation Therapy Process Management System RT-Link," and "Intelligent Radiation Therapy Integrated Solution RT-Solution." Based on these, it has built planning and navigation products covering multiple sites and diseases, including the heart, lungs, and liver, forming a complete product matrix.
One-stop Solution for Tumor Radiotherapy, AI-driven Precision Radiation Therapy to Achieve Automation in Tumor Treatment. Automatic Contouring, Automatic Planning, Automatic Quality Control, FDA-approved.
● Demand Description:
Seeking overseas channel distributors, agent resources, and international business expansion.
Lingyi Zhihui - China's First Industrial-Grade Medical Large Model
●Company/Product Introduction:
Lingyi Zhihui is Baidu's AI medical brand, adhering to the vision of "Evidence-based AI Empowering the Greater Health Industry." Relying on the core technologies and AI capabilities of Baidu Brain, it has built a Medical AI Middleware, Medical Knowledge Middleware, and Medical Data Middleware. Its products and services cover various areas in the medical field, including the enhanced Lingyi Large Model and its applications, Clinical Decision Support Systems (CDSS), connotation quality control of medical records, DRG/DIP intelligent cost control, single-disease reporting and quality control, medical big data services, and research platforms. Leveraging technological power, it makes high-quality medical resources more accessible. In recent years, it has conducted in-depth practices in four aspects: assisting hospitals, empowering the government, benefiting patients, and serving pharmaceuticals and medical devices. Its commitment to social responsibility has never ceased as it continuously outputs AI medical capabilities to society, helping improve the efficiency and quality of the medical industry. It hopes to use technology to actively assist the country in achieving the "Healthy China 2030" strategy as soon as possible. Currently, it has been implemented in over 800 hospitals and more than 4,000 grassroots medical institutions across China.
Lingyi Large Model
Product Features:
· High-quality Chinese general large model base, independently developed in China based on the Wenxin pre-trained model foundation, with multiple enhancement technologies such as knowledge, retrieval, and context.
· Ten-thousand-card computing power and toolchain support, ten-thousand-card scale computing clusters, full lifecycle model development toolchain.
· Deep accumulation in the medical industry, training data with hundreds of billions of tokens in healthcare corpus, and over a hundred types of medical AI machine learning tasks.
● Demand Description:
Seeking distributors and partners across China. Interested parties are welcome to communicate.
Guangzhou Nandafei Medical and Health Technology Co., Ltd. - AI Intelligent Agent
●Company/Product Introduction:
Guangzhou Nandafei Medical and Health Technology Co., Ltd. was established in April 2014 and is the first company in China to initiate medical weight management, diabetes management, and standardized nutritional intervention services. In response to policy calls such as the "Healthy China 2030" Plan Outline, and with the support of several endocrinology professor teams from Southern Medical University, the Guangdong Association of Integrative Medicine's Obesity and Weight Management Professional Committee, and the Guangdong Preventive Medicine Association's Endocrine and Metabolic Disease Prevention and Treatment Professional Committee, the company has integrated cutting-edge research literature and medical guidelines. Since 2014, it has supported over 40 tertiary hospitals in regions such as Guangdong Province and Jiangsu Province, as well as JD Health and Meinian Health, in implementing intervention management for overweight/obese populations. It provides personalized lifestyle intervention plans, supporting products, and online follow-up services at the family end for target patients. To date, it has helped more than 30,000 patients lose weight and reduce fat, stabilize blood sugar control, and improve chronic disease indicators. The company has consecutively been named one of the top 50 enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area for four times, received the High-tech Enterprise designation twice, won the title of one of the top 20 AIGC healthcare companies in the 2023 China Innovation and Entrepreneurship Competition, and was selected as an outstanding case in weight management by the National Center for Chronic and Non-communicable Disease Control and Prevention in 2024.
AI Agent
Utilize AI-powered dynamic blood glucose monitoring and health management workflows, combined with the scientific allocation of functional nutrients, to customize a "personalized strategy for each individual" in terms of medication guidance, dietary adjustments, and exercise recommendations for every user.
● Demand Description:
Seeking collaboration with labor-intensive chronic disease management enterprises, hospitals/internet hospitals, chronic disease prevention and control institutions, and chronic disease pharmaceuticals/medical device companies. Interested parties are welcome to communicate.
Ningbo Leadart Biotechnology Co., Ltd. - Automated Drug Target Histone Preparation System
●Company/Product Introduction:
Ningbo Leadart Biotechnology Co., Ltd. is China's first and one of the world's first biotechnology companies based on chemical proteomics technology, and also the world's first company to successfully achieve an automated chemical proteomics-based drug discovery platform. Leadart has mastered the most cutting-edge chemobiology technologies in the world and utilizes "target fishing probe" technology in the proteome to enable rapid screening of early-stage new drugs in living human cells.
Ningbo Leadart Biotechnology Co., Ltd., leveraging its leading position in the field of chemical proteomics, launched the world's first fully automated chemical proteomics sample preparation system, "Target Space Station," in October 2023, establishing its market leadership within the industry. This system represents an innovative solution for the pharmaceutical research and development sector, designed to accelerate the discovery of drug targets and the screening of new target ligands.
● Demand Description:
Seeking relevant partners such as pharmaceutical companies and research institutions.
Arimedy-MOST Integrated Smart Surgery Solution Technology Platform
● Enterprise/ProductIntroduction：
Arimedy Medical Technology (Beijing) Co., Ltd. is a national high-tech enterprise specializing in the research, production, and sales of core medical sensors and digital diagnosis and treatment equipment series products. It provides a full range of integrated smart surgery solutions centered around intelligent digital diagnosis and treatment equipment such as surgical robots and medical imaging devices.
Arimedy Medical Technology (Beijing) Co., Ltd. relies on its mature full-process capabilities in R&D, testing, clinical trials, and certification. With the MOST R&D system as the core of its business implementation, the company has established a comprehensive solution for smart surgery, including product development and technical implementation systems. It addresses the high-precision positioning needs of doctors throughout the surgical process. Using core navigation components as the foundation, Arimedy constructs a technical implementation system for one-stop smart surgery solutions, offering multiple solutions such as surgical robots, intelligent imaging equipment, augmented reality simulation, intelligent motion rehabilitation, and smart physiological monitoring.
● Requirement Description：
Seeking relevant partners such as agents and hospitals.
Beijing Health&Biotech Group Corp.Ltd. - Stem Cell Regenerative Medicine Technology
●Enterprise/ProductIntroduction：
Beijing Health&Biotech Group Corp.Ltd. has laid out the entire industrial chain with stem cell regenerative medicine technology as its core. As a nationally recognized high-tech enterprise, Health&Biotech Group has established six stem cell banks across China, all built and put into operation according to GMP standards; it has also set up multiple stem cell research and development branches nationwide, providing high-standard regenerative medicine research platforms for hospitals, universities, and scientific research institutions both domestically and internationally. The group's development encompasses over 20 subsidiaries and has established its European R&D center, H&B France, in France, with business coverage extending both domestically and overseas.
In 2020, Beijing Health&Biotech Group Corp.Ltd. established the Hans BioArk platform, which focuses on stem cell technology to safeguard the health of entire families. The platform covers five major sectors: cell storage, Hans Medical, My Cell Center, biological skincare, and Cell Valley, aiming to create a customized health management center for the entire life cycle.
● Requirement Description：
Recruit ecosystem partners related to the stem cell field, including enterprises, product distributors, research institutes, and hospitals.
Hangzhou Tiancheng Technology - Digital Scent Solution
●Enterprise/ProductIntroduction：
Technical Route: Provide odor simulation, odor storage, precise odor release, directional transmission, integration with large AI models, and molecular fusion in gaseous states.
Mainly concentrated in the drug research and development stage, including target identification, drug screening, molecular synthesis, etc. AI can accelerate the drug discovery and design process through technologies such as data mining, machine learning, and deep learning, improving R&D efficiency and success rates. In addition, AI can also play a role in quality control, process optimization, and intelligent management in drug production, enhancing the production efficiency and quality of drugs.
● Requirement Description：
Seeking Market Partners. Application Scenarios for AI Digital Scent Technology: Digital Doctors and Health Management, Rehabilitation Treatment in Rehabilitation Hospitals, Personalized Management of Chronic Diseases, Beauty and Body Care, Traditional Chinese Medicine Rehabilitation Centers, Traditional Chinese Medicine Health Management.
Beijing Jianjian Medical Technology Co., Ltd. - IoT + Medical Testing Data Transmission and Intelligent Analysis Technology
●Enterprise/ProductIntroduction：
Beijing Jianjian Medical Technology Co., Ltd. centers on its self-developed technology, the "AI Digital Intelligence Health Brain," forming a digital platform + intelligent hardware + refined operation system that runs through the "screening, testing, prevention, treatment, management, and rehabilitation" industrial ecosystem chain. Main application scenarios include digital public health, integrated primary care for chronic diseases, national health information platforms, closely-knit medical communities, elderly rehabilitation, and weight management.
Full-process intelligent and standardized governance is implemented for China's basic public health services, optimizing traditional work models and enhancing the efficiency and quality of corresponding services. It can be flexibly applied in various scenarios such as within hospitals, communities, and rural areas to conduct public health examinations and Traditional Chinese Medicine (TCM) health management services. The system supports multi-regional synchronized operations and multi-person simultaneous testing, ensuring efficient and orderly service delivery. Data is automatically collected, transmitted, and processed, with reports generated immediately after each examination. The smart hardware features an integrated multifunctional design, wireless connectivity, and is portable and easy to store. The operating system adopts a one-touch design and multi-role management, making it smarter and more practical.
● Demand Description：
Seeking market partners such as channel partners.
Boea Wisdom-DetecMicro® Vascular Interventional Surgery Planning Software
●Enterprise/ProductIntroduction：
Boea Wisdom has achieved China's first domestically produced surgical planning software that integrates structural analysis and treatment selection. Its DetecMicro(®) vascular interventional surgery planning software, based on medical imaging data, provides refined analysis and interpretation of patients' cardiovascular diseases, offering comprehensive assistance for interventional surgical plans such as EVAR, TEVAR, and TAVI to clinicians. In November last year, the product officially passed the third-class medical device registration approval by the National Medical Products Administration (NMPA) in China (Registration No.: 20233211596).
● Requirement Description：
① Provincial Strategic Cooperation Distributor: Responsible for product promotion and coverage within the province.
②Precision Partners: Complete project implementation within a specified timeframe on a project-by-project basis.
iRegene-iReOrgan Has Independent Intellectual Property Rights
Chemically Induced Organoid Platform
iRegene has established an integrated organoid R&D platform (iReOrgan) based on "AI + chemical induction." The organoid models produced by this platform not only provide disease characterization but also reflect the spatiotemporal changes of diseases, making them a rare type of organoids in the current market. The existing iReOrgan platform has achieved large-scale cultivation and developed a series of complex organoids and their derived disease models, including whole-brain organoids, midbrain organoids, heart organoids, etc., which can simultaneously perform high-throughput screening and validation of candidate drugs while constructing models.
● Demand Description：
iRegene's iReOrgan platform can provide a wealth of scientific research and industrial services, and welcomes relevant research and corporate collaboration projects.
EBrain Scientific - Brain-Computer System Dedicated to Brain Health Care and Training
Chongqing Tongjian Intelligent Medical Technology Co., Ltd. is a digital and intelligent medical testing operation service provider. Through "Tongjian," an integrated internet + testing service platform, it consolidates various testing resources to provide personalized, one-stop, full-course digital and intelligent testing services for individual users as well as internet healthcare and health service institutions.
Goal: Create a "30-minute testing and inspection circle" to occupy the user's mindset of "choose Tongjian for tests and inspections."
In order to ensure the stability, security, accessibility, and other requirements of the service, we are now seeking cooperation.
●Requirement Description：
Scope of Partner Institutions:
Regular medical institutions equipped with laboratories (public/private hospitals (including specialty hospitals such as dental and ophthalmic hospitals), community health service institutions, outpatient clinics, departmental laboratories), third-party testing laboratories, etc.
IVD manufacturers, self-inspection, sample submission for testing, on-site testing and other product services.
①Interested in the above-mentioned enterprise products, or currently paying attention to products in other fields.
② If you have any medical innovation products and want to participate in the weekly link promotion plan
Welcome to scan the QR code below to contact us.
- VCBeat Supply and Demand Platform Coverage: Overseas Expansion, Supply Chain, Market/Channels, Achievement Transformation, Investment Attraction and Residency, etc.
- By uploading supply or demand resources through the platform, you can precisely reach potential target partners.
- Efficiently connect with MNCs, startups, government parks, investment institutions, and other entities.
>>>>
Download the VCBeat APP, self-publish, and efficiently connect.
